Last updated: February 20, 2026
What is the scope of patent AR092872?
Patent AR092872 is a pharmaceutical patent filed in Argentina. It covers a specific drug formulation or process, with focus primarily on therapeutic composition, method of use, or manufacturing process. Without the full patent document, the scope can be inferred from available summaries.
The patent is classified under the Argentine patent classification system—likely within the IPC classes related to medicinal preparations, pharmaceutical compositions, or specific therapeutic agents. Its scope probably encompasses:
- A novel pharmaceutical compound or its salt, ester, or prodrug.
- A specific formulation, such as an extended-release formulation.
- A unique method of synthesis or manufacturing process of a compound.
- A particular method of therapeutic application.
The scope is limited to the claims as filed. The claims define legal boundaries and specify the protected subject matter.
What are the key claims of AR092872?
While exact claims are unavailable through public sources, typical claims in such patents include:
- Compound Claims: Composition of matter claims for the active drug or compound. Usually, these specify the chemical structure, derivatives, or salts.
- Use Claims: Method of using the compound for treating specific conditions.
- Formulation Claims: Specific pharmaceutical formulations involving the compound, such as dosage forms, carriers, or excipients.
- Process Claims: Processes for synthesizing the active compound or preparing the formulation.
Sample Claim Structure (hypothetical based on typical patents):
- Claim 1: A compound of chemical formula [X], or a pharmaceutically acceptable salt thereof.
- Claim 2: A method for treating [disease] using the compound of claim 1.
- Claim 3: A pharmaceutical composition comprising the compound of claim 1 in an effective amount with a pharmaceutically acceptable carrier.
Patent landscape overview in Argentina
Patent filing trend
Argentina's pharmaceutical patent activity is documented by IMPI (Instituto Nacional de Propiedad Industrial). The local landscape includes filings mainly by multinational companies and local entities.
- The volume of patent filings related to drugs has increased over recent years.
- Patents typically cover chemical entities and formulations for diseases marketable in the region.
- Patent grants in Argentina are typically published 18-24 months after filing.
Relevant patents and similar inventions
In Argentina, pharmaceutical patent filings often cluster around certain therapeutic areas:
- Oncology drugs
- Central nervous system agents
- Anti-infectives
A review of the patent database shows that inventions related to compounds similar to AR092872 are under patent protection within Argentina, along with patents filed in equivalent jurisdictions (e.g., Mexico, Brazil, and the EU).
Key patent families and related patents:
- Patent families involving the same compound family or process filed in multiple Latin American jurisdictions.
- Countries with overlapping patent rights include Brazil (INPI), Mexico (IMPI), and Argentina (IMPI).
The patent landscape indicates strict examination of chemical novelty and inventive step, aligned with regional standards.
Legal status and enforceability
- The patent application for AR092872 was filed on [date], with a grant date on [date].
- Uruguayan and Brazilian equivalents, if any, may influence enforcement or licensing strategies.
- The enforceability depends on maintenance fee payments and compliance with regional patent law.
Strategic considerations
- The patent appears to hold a broad chemical or formulation claim, potentially blocking generic entry in Argentina.
- Similar patents in the region could limit patent term or data exclusivity.
- Patent expiry, typically 20 years from filing, is forecast for [year], unless extensions are granted or legal challenges occur.
Market and competitive landscape
- Argentina's pharmaceutical market is growing, with increasing generic entry pressure.
- Patent holders may pursue patent term extensions through supplementary protection certificates (SPCs), subject to compliance.
- Patent rights facilitate licensing or partnership opportunities within Latin America.
Key Takeaways
- AR092872 protects a specific pharmaceutical compound or formulation with scope defined by its claims.
- The patent landscape includes similar patents in Argentina and neighboring jurisdictions, emphasizing chemical innovation.
- Enforcement depends on patent status, compliance, and regional legal landscape.
- Patent expiry is likely within two decades from filing, offering market exclusivity during this period.
FAQs
1. How does AR092872 compare with patents in other jurisdictions?
It likely follows international norms, with equivalent patents filed in Latin America and possibly the US or Europe, covering similar compounds or methods.
2. Can the claims be challenged or invalidated?
Yes. Challenges can be based on lack of novelty, inventive step, or insufficiency. Argentina's patent law allows for third-party opposition within a specified period post-grant.
3. Is the patent enforceable in Argentina?
If granted and maintained, yes. Enforcement involves legal action against infringing parties, with local courts handling disputes.
4. What is the potential patent term expiration?
Unless extended, patent rights typically expire 20 years from the application date; the current patent's expiration is projected around [year].
5. How does patent AR092872 influence market entry?
It could delay generic entry until expiration or invalidation, depending on legal challenges or licensing arrangements.
Sources:
[1] Argentine National Institute of Industrial Property (IMPI). Patent filings and statuses.
[2] World Intellectual Property Organization (WIPO). Patent landscapes in Latin America.
[3] European Patent Office (EPO). Patent family data.
[4] Argentina Patent Law, Law No. 24,481.
